AHA 2019: Colchicine in Percutaneous Coronary Intervention (PCI) — Dr Binita Shah





The interactive transcript could not be loaded.


Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Dec 12, 2019

Dr Binita Shah (NYU Langone Health, New York, NY, US) discusses Colchicine in Percutaneous Coronary Intervention (PCI).

1.What is colchicine and why study it in PCI?
2.What was the study design, patient population and primary and secondary outcomes?
3.What were your outcomes?
4.How do these compare to those in the COLCOT study?
5.How should your study be interpreted in clinical practice and influence further research in this field?

Filmed on site at AHA 2019 by Radcliffe Cardiology.
Interviewer: Liam O'Neill / Videographer: Tom Green & Dominic Woodruff

See more videos here : https://www.radcliffecardiology.com/v...
RC Academy : https://www.radcliffecardiology.com/r...

radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions.


to add this to Watch Later

Add to

Loading playlists...